Dipeptidyl peptidase-4 inhibitors: the different dosing requirements of adult patients with type 2 diabetes and comorbidities

20190823 Trajenta diabetes flyer v9 cover

This management algorithm has been commissioned and funded by Boehringer Ingelheim Limited and Lilly Diabetes Alliance.

Content for healthcare professionals

Access to this content is restricted to UK-based doctors, nurses, and pharmacists

If you are a UK-based doctor, nurse, or pharmacist, you must sign in to your account or register (for free) if you do not already have one. 

Return to homepage